Fiduciary Family Office’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Sell
11,566
-2,577
-18% -$375K 0.42% 46
2026
Q1
$2.04M Buy
14,143
+8,921
+171% +$1.35M 0.58% 34
2025
Q4
$748K Sell
5,222
-4,012
-43% -$592K 0.22% 82
2025
Q3
$1.42M Buy
9,234
+915
+11% +$143K 0.4% 44
2025
Q2
$1.33M Buy
8,319
+181
+2% +$29.5K 0.43% 44
2025
Q1
$1.39M Buy
+8,138
New +$1.36M 0.46% 43
2024
Q4
Sell
-7,283
Closed -$1.26M 202
2024
Q3
$1.26M Buy
7,283
+3,040
+72% +$516K 0.42% 50
2024
Q2
$700K Sell
4,243
-1,056
-20% -$173K 0.28% 93
2024
Q1
$860K Sell
5,299
-1,053
-17% -$165K 0.34% 85
2023
Q4
$931K Buy
+6,352
New +$941K 0.41% 47

Other funds holding PG

Fiduciary Family Office's PG Position: Q2 2026 in Review

Fiduciary Family Office reduced its Procter & Gamble (PG) stake by 18% in Q2 2026, selling an estimated $375K and leaving 11,566 shares worth $1.7M. The position accounts for 0.42% of the portfolio, ranked #46.

Fiduciary Family Office first reported a position in PG in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.04M in Q1 2026. 4,028 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Fiduciary Family Office held 11,566 shares of Procter & Gamble worth $1.7M as of Q2 2026.
  • Fiduciary Family Office sold 2,577 Procter & Gamble shares in Q2 2026, an estimated $375K.
  • Procter & Gamble made up 0.42% of Fiduciary Family Office's portfolio in Q2 2026, its #46 holding.
  • Fiduciary Family Office first reported a position in Procter & Gamble in Q4 2023 and has held it in 10 quarters since.
  • Fiduciary Family Office's Procter & Gamble position peaked at $2.04M in Q1 2026.
  • 4,028 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.